Literature DB >> 22499543

Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007.

Isuru Ranasinghe1, Chris Naoum, Bernadette Aliprandi-Costa, Andrew P Sindone, P Gabriel Steg, John Elliott, Bruce McGarity, Jeffrey Lefkovits, David Brieger.   

Abstract

AIM: The outcome of patients with chronic heart failure (CHF) following an ischaemic event is poorly understood. We evaluated the management and outcomes of CHF patients presenting with an acute coronary syndrome (ACS) and explored changes in outcomes over time. METHOD AND
RESULTS: A total of 5556 patients enrolled in the Australia-New Zealand population of the Global Registry of Acute Coronary Events (GRACE) between 1999 and 2007 were included. Patients with CHF (n = 609) were compared with those without CHF (n = 4947). Patients with CHF were on average 10 years older, were more likely to be female, had more co-morbidities and cardiac risk factors, and were more likely to have a prior history of angina, myocardial infarction, and revascularization by coronary artery bypass graft (CABG) when compared with those without CHF. CHF was associated with a substantial increase in in-hospital renal failure [odds ratio (OR) 1.76, 95% confidence interval (CI) 1.15-2.71], readmission post-discharge (OR 1.47, 95% CI 1.17-1.90), and 6-month mortality (OR 2.25, 95% CI 1.55-3.27). Over the 9 year study period, in-hospital and 6 month mortality in those with CHF declined by absolute rates of 7.5% and 14%, respectively. This was temporally associated with an increase in prescription of thienopyridines, beta-blockers, statins, and angiotensin II receptor blockers, increased rates of coronary angiography, and 31.8% absolute increase in referral rates for cardiac rehabilitation.
CONCLUSIONS: Acute coronary syndrome patients with pre-existing CHF are a very high risk group and carry a disproportionate mortality burden. Encouragingly, there was a marked temporal improvement in outcomes over a 9 year period with an increase in evidence-based treatments and secondary preventative measures.

Entities:  

Mesh:

Year:  2012        PMID: 22499543     DOI: 10.1093/eurjhf/hfs041

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  5 in total

1.  Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes.

Authors:  Batric Popovic; Nelly Agrinier; Damien Voilliot; Mazen Elfarra; Jean Pierre Villemot; Pablo Maureira
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

2.  A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project.

Authors:  Peng Ran; Jun-Qing Yang; Jie Li; Guang Li; Yan Wang; Jia Qiu; Qi Zhong; Yu Wang; Xue-Biao Wei; Jie-Leng Huang; Chung-Wah Siu; Ying-Ling Zhou; Dong Zhao; Dan-Qing Yu; Ji-Yan Chen
Journal:  Ann Transl Med       Date:  2021-01

3.  Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia.

Authors:  Michael O Falster; Andrea L Schaffer; Andrew Wilson; Arthur Nasis; Louisa R Jorm; Melanie Hay; Kira Leeb; Sallie-Anne Pearson; David Brieger
Journal:  Intern Med J       Date:  2022-02       Impact factor: 2.611

4.  Heart failure: the need for global health perspective.

Authors:  Amitava Banerjee; Shanthi Mendis
Journal:  Curr Cardiol Rev       Date:  2013-05

Review 5.  Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines.

Authors:  Pupalan Iyngkaran; Nadarajan Kangaharan; Hendrik Zimmet; Margaret Arstall; Rob Minson; Merlin C Thomas; Peter Bergin; John Atherton; Peter MacDonald; David L Hare; John D Horowitz; Marcus Ilton
Journal:  Curr Cardiol Rev       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.